Showing results (81-90 of 138) with videos related to
Sort By:
Pageof 14
Evidence-Based Complementary and Alternative Medicine : Ecam|December 25, 2019
The Herb-Drug Pharmacokinetic Interaction of Fluoxetine and Its Metabolite Norfluoxetine with a Traditional Chinese Medicine in Rats by LC-MS/MSLijing Yan, Sheng Wang, Linlin Zhao, et al.Biomed Research International|March 19, 2020
Antidepressant-Like Effects and Cognitive Enhancement of Coadministration of Chaihu Shugan San and Fluoxetine: Dependent on the BDNF-ERK-CREB Signaling Pathway in the Hippocampus and Frontal CortexLijing Yan, Xia Xu, Zhenyu He, et al.European Journal of Cardiovascular Nursing|February 19, 2026
Efficacy of digital psychological interventions for psychological outcomes in cardiovascular patients: A systematic review and network meta-analysisMinjuan Ding, Meichang Wang, Manzhi Gao, et al.Dalton Transactions (Cambridge, England : 2003)|June 28, 2024
A sheet-like tin-based metal-organic framework with enhanced lithium storageZikang Ruan, Tingting Jiang, Xianhe Meng, et al.Food Research International (Ottawa, Ont.)|January 3, 2023
Diet-rich in wheat bran modulates tryptophan metabolism and AhR/IL-22 signalling mediated metabolic health and gut dysbacteriosis: A novel prebiotic-like activity of wheat branTao Yan, Lin Shi, Tianqi Liu, et al.Oncotarget|December 8, 2016
Metformin therapy and risk of colorectal adenomas and colorectal cancer in type 2 diabetes mellitus patients: A systematic review and meta-analysisFeifei Liu, Lijing Yan, Zhan Wang, et al.Stroke|April 22, 2006
Prior events predict cerebrovascular and coronary outcomes in the PROGRESS trialHisatomi Arima, Christophe Tzourio, Ken Butcher, et al.Circulation|September 8, 2005
Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging SubstudyCarole Dufouil, John Chalmers, Oguzhan Coskun, et al.Diabetes, Obesity & Metabolism|March 30, 2021
Sex differences in risk factors for cognitive decline and dementia, including death as a competing risk, in individuals with diabetes: Results from the ADVANCE trialJessica Gong, Katie Harris, Maree Hackett, et al.Systematic Reviews|November 30, 2012
Study protocol: systematic review of the burden of heart failure in low- and middle-income countriesDerrick A Bennett, Thomas K Eliasz, Anna Forbes, et al.Pageof 14